Protein kinases: drug targets for immunological disorders

L Castelo-Soccio, H Kim, M Gadina… - Nature Reviews …, 2023 - nature.com
Protein kinases play a major role in cellular activation processes, including signal
transduction by diverse immunoreceptors. Given their roles in cell growth and death and in …

Bruton's tyrosine kinase inhibitors (Btkis): review of Preclinical studies and evaluation of clinical trials

D Rozkiewicz, JM Hermanowicz, I Kwiatkowska… - Molecules, 2023 - mdpi.com
In the last few decades, there has been a growing interest in Bruton's tyrosine kinase (BTK)
and the compounds that target it. BTK is a downstream mediator of the B-cell receptor (BCR) …

Human iPS cell-derived sensory neurons can be infected by SARS-CoV-2

A Flamier, P Bisht, A Richards, DL Tomasello… - Iscience, 2023 - cell.com
COVID-19 has impacted billions of people since 2019 and unfolded a major healthcare
crisis. With an increasing number of deaths and the emergence of more transmissible …

Inflammatory pathways in COVID‐19: mechanism and therapeutic interventions

Y Jiang, T Zhao, X Zhou, Y **ang… - MedComm, 2022 - Wiley Online Library
Abstract The 2019 coronavirus disease (COVID‐19) pandemic has become a global crisis.
In the immunopathogenesis of COVID‐19, SARS‐CoV‐2 infection induces an excessive …

B-cell malignancies treated with targeted drugs and SARS-CoV-2 infection: A European Hematology Association Survey (EPICOVIDEHA)

MS Infante, J Salmanton-García… - Frontiers in …, 2022 - frontiersin.org
Patients with lymphoproliferative diseases (LPD) are vulnerable to severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) infection. Here, we describe and analyze the …

[HTML][HTML] In-silico study for the identification of potential destabilizers between the spike protein of SARS-CoV-2 and human ACE-2

J Medina-Barandica, N Contreras-Puentes… - Informatics in Medicine …, 2023 - Elsevier
The emergence of the new SARS-CoV-2 virus, which causes the disease known as COVID-
19, has generated a pandemic that has plunged the world into a health crisis. The infection …

Thrombotic and bleeding complications in patients with chronic lymphocytic leukemia and severe COVID-19: a study of ERIC, the European Research Initiative on …

D Antic, N Milic, T Chatzikonstantinou, L Scarfò… - Journal of hematology & …, 2022 - Springer
Background Patients with chronic lymphocytic leukemia (CLL) may be more susceptible to
COVID-19 related poor outcomes, including thrombosis and death, due to the advanced …

Antiviral therapy of COVID-19

G Gudima, I Kofiadi, I Shilovskiy, D Kudlay… - International Journal of …, 2023 - mdpi.com
Since the beginning of the COVID-19 pandemic, the scientific community has focused on
prophylactic vaccine development. In parallel, the experience of the pharmacotherapy of this …

Tetrabromobisphenol A effects on differentiating mouse embryonic stem cells reveals unexpected impact on immune system

A Tribondeau, LM Sachs, N Buisine - Frontiers in Genetics, 2022 - frontiersin.org
Tetrabromobisphenol A (TBBPA) is a potent flame retardant used in numerous appliances
and a major pollutant in households and ecosystems. In vertebrates, it was shown to affect …

A Review on Role of Inflammation in Coronavirus Disease

A Lotfi, P Hajian, L Abbasi, MK Gargari… - … Metabolic & Immune …, 2024 - benthamdirect.com
The respiratory illness known as COVID-19 is caused by the novel coronavirus, SARS-CoV-
2. While the precise pathogenic mechanism of COVID-19 remains unclear, the occurrence of …